{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:20Z","timestamp":1787068460159,"version":"build-2736575974"},"reference-count":80,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4254\/wjh.v7.i12.1617","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T04:47:30Z","timestamp":1435121250000},"page":"1617","source":"Crossref","is-referenced-by-count":66,"title":["Predictive factors associated with hepatitis C antiviral therapy response"],"prefix":"10.4254","volume":"7","author":[{"given":"Lourianne Nascimento","family":"Cavalcante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-4-201202210-00004"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50061"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12168"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00078-8"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nature08309"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.449"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012912"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3310\/hta8390"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24052"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.076646"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808010"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21932"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0027-1"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02653.x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.06.008"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22223"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23912"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/ng.447"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nature08463"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.05.079"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling MH, Albrecht J. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303-1313.","DOI":"10.1053\/gast.2002.33023"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.074062"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1086\/507307"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27281"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24575"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02382.x"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.04.009"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.12816\/0006339"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12106"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-28032010000200009"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101931"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.12.027"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.032"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.042"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Manns MP, Markova AA, Calle Serrano B, Cornberg M. Phase III results of Boceprevir in treatment na&iuml;ve patients with chronic hepatitis C genotype 1. Liver Int 2012;32 Suppl 1:27-31.","DOI":"10.1111\/j.1478-3231.2011.02725.x"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908014"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013086"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.023"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2012.45.3.217"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.011"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009482"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.023"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i47.8963"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02718.x"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.051"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998;282:103-107.","DOI":"10.1126\/science.282.5386.103"},{"key":"ref52","unstructured":"Neumann AU. AIDSinfo Drug Database. [Accessed 2015 Jan 31] Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/aidsinfo.nih.gov\/drugs\/488\/boceprevir\/0\/patient\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/aidsinfo.nih.gov\/drugs\/488\/boceprevir\/0\/patient<\/ext-link>."},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12230"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit226"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu340"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03430.x"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61036-9"},{"key":"ref58","unstructured":"Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C. [Accessed 2015 Jan 31] Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcvguidelines.org\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hcvguidelines.org\/<\/ext-link>."},{"key":"ref59","unstructured":"European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2014. [Accessed 2015 Jan 31] Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.easl.eu\/_newsroom\/latest-news\/easl-recommendations-on-treatment-of-hepatitis-c-2014\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.easl.eu\/_newsroom\/latest-news\/easl-recommendations-on-treatment-of-hepatitis-c-2014<\/ext-link>."},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27296"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60494-3"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60538-9"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307498"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70138-X"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.045"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402338"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401561"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Lawitz E, Hezode C, Gane E, Tam E, Lagging M, Balart L, Rossaro L, Ghalib R, Shaughnessy M, Hwang P, Wahl J, Robertson M, Haber B. Efficacy and safety of MK-5172 and MK-8742 \u00b1 ribavirin in hepatitis C genotype 1 infected patients with cirrhosis or previous null-response: the C-WORTHY study Program and abstracts of the 49th Annual Meeting of the European Association for the Study of the Liver; April 9-13, 2014; London: England; 2014;.","DOI":"10.1016\/S0168-8278(14)60063-5"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25976"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.09.023"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21646"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22175"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21121"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12406"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.001"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.06.004"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v7\/i12\/1617.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T13:12:14Z","timestamp":1566911534000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v7\/i12\/1617.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v7.i12.1617","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}